Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement

BACKGROUND: This single-arm, multicenter, phase 2 study evaluated the safety and antitumor activity of pazopanib in patients with unresectable, pulmonary metastatic osteosarcoma. Patients and Methods. Patients with pulmonary metastatic osteosarcoma unresponsive to chemotherapy were eligible. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankel, Paul, Ruel, Chris, Uche, An, Choy, Edwin, Okuno, Scott, Somiah, Neeta, Chow, Warren A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783732/
https://www.ncbi.nlm.nih.gov/pubmed/35075361
http://dx.doi.org/10.1155/2022/3691025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783732/
https://www.ncbi.nlm.nih.gov/pubmed/35075361
http://dx.doi.org/10.1155/2022/3691025

Ejemplares similares